Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amgen, FDA Ready For Another REMS Go Around With Prolia

Aug 24 2009

• By The Pink Sheet

Related Content

ODAC Will Review Denosumab SRE Data If FDA Requires Advisory Committee

Aug 24 2009

As Amgen's Prolia Goes, So Goes The Market: Reaction To AC Recs

Aug 17 2009

Amgen's Mixed Advisory Committee Votes On Prolia Still Offer A Good Start

Aug 13 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window